Option Care Health, Inc. (OPCH) is a publicly traded company in the Healthcare sector, operating within the Medical - Care Facilities industry. The company is headquartered in Bannockburn, IL, United States. The current CEO is John C. Rademacher.
OPCH has IPO date of 1996-08-15, 8,000 full-time employees, listed on the NASDAQ Global Select, a market capitalization of $4.36B.
Option Care Health, Inc. is a leading provider of home and alternate site infusion services throughout the United States, headquartered in Bannockburn, Illinois. The company delivers a comprehensive range of specialized therapies including anti-infective treatments, home infusion services for heart failure, parenteral and enteral nutrition support, immunoglobulin therapies, and treatments for chronic inflammatory disorders such as Crohn's disease, rheumatoid arthritis, and ulcerative colitis. Additionally, Option Care Health provides therapies for neurological disorders, bleeding disorders, high-risk pregnancy management, and other infusion-based treatments including pain management, chemotherapy, and respiratory medications, supported by integrated nursing services.
